Based on these observations, Daggett et al. designed α-sheet peptides that are complementary to α-sheet structures of amyloid-β and TTR, and confirmed their activity against amyloidosis [60,61], supporting the hypothesis that α-sheet structures are an intermediate state in the amyloidosis pathway. Here, TTR is linked to amyloidosis.